AAPL341.15+1.65 (+0.49%) ▲|ABBV286.36-2.60 (-0.90%) ▼|ABT99.16-3.29 (-3.21%) ▼|ACN239.63+0.51 (+0.21%) ▲|ADBE256.33-0.40 (-0.16%) ▼|AMAT407.98+3.00 (+0.74%) ▲|AMD542.98+8.24 (+1.54%) ▲|AMGN436.48-2.46 (-0.56%) ▼|AMT179.77-3.79 (-2.06%) ▼|AMZN260.04-2.59 (-0.99%) ▼|AVGO333.80-0.57 (-0.17%) ▼|AXP321.75+3.41 (+1.07%) ▲|BA191.87+1.40 (+0.74%) ▲|BAC50.73+0.09 (+0.18%) ▲|BKNG157.99-5.93 (-3.62%) ▼|BLK1,132.51+3.83 (+0.34%) ▲|BMY61.25-0.44 (-0.71%) ▼|BNY145.28+1.03 (+0.71%) ▲|BRK-B541.72+1.90 (+0.35%) ▲|C122.60+0.09 (+0.07%) ▲|CAT734.01+8.77 (+1.21%) ▲|CL93.58-0.96 (-1.02%) ▼|CMCSA21.80-0.57 (-2.53%) ▼|COF209.72+8.16 (+4.05%) ▲|COP146.24+0.29 (+0.20%) ▲|COST990.15-4.46 (-0.45%) ▼|CRM241.54-0.90 (-0.37%) ▼|CSCO107.36+0.65 (+0.60%) ▲|CVS94.10-0.66 (-0.69%) ▼|CVX226.91+1.20 (+0.53%) ▲|DE628.79-3.41 (-0.54%) ▼|DHR228.90+4.66 (+2.08%) ▲|DIS110.58-1.09 (-0.98%) ▼|DUK121.17-0.16 (-0.13%) ▼|EMR161.89+1.43 (+0.89%) ▲|FDX298.94+0.18 (+0.06%) ▲|GD345.69+1.25 (+0.36%) ▲|GE304.97+5.10 (+1.70%) ▲|GEV921.39+31.06 (+3.49%) ▲|GILD152.75-3.76 (-2.40%) ▼|GM75.77-1.32 (-1.71%) ▼|GOOG327.00-9.40 (-2.79%) ▼|GOOGL331.07-9.21 (-2.71%) ▼|GS891.05+6.24 (+0.70%) ▲|HD313.58-1.53 (-0.48%) ▼|HON214.76+1.44 (+0.67%) ▲|IBM244.12+2.20 (+0.91%) ▲|INTC91.80+0.11 (+0.11%) ▲|INTU333.34-1.96 (-0.58%) ▼|ISRG418.37-19.63 (-4.48%) ▼|JNJ255.38-3.99 (-1.54%) ▼|JPM333.44-1.82 (-0.54%) ▼|KO92.86-0.64 (-0.68%) ▼|LIN500.09-1.80 (-0.36%) ▼|LLY1,266.98-16.68 (-1.30%) ▼|LMT548.71+0.00 (+0.00%) ▲|LOW195.92-1.36 (-0.69%) ▼|LRCX265.10+1.65 (+0.63%) ▲|MA621.11+0.69 (+0.11%) ▲|MCD244.10-2.42 (-0.98%) ▼|MDLZ63.16-0.83 (-1.30%) ▼|MDT93.77-0.87 (-0.91%) ▼|META704.66+10.41 (+1.50%) ▲|MMM170.67-0.70 (-0.41%) ▼|MO74.12-0.53 (-0.70%) ▼|MRK148.65+0.35 (+0.24%) ▲|MS181.69+1.29 (+0.72%) ▲|MSFT529.51-2.36 (-0.44%) ▼|MU904.87+8.80 (+0.98%) ▲|NEE78.56-0.30 (-0.38%) ▼|NFLX65.92-2.77 (-4.03%) ▼|NKE37.57-0.32 (-0.83%) ▼|NOW151.90+2.36 (+1.57%) ▲|NVDA218.12+1.65 (+0.76%) ▲|ORCL129.46-1.68 (-1.28%) ▼|PEP134.35+0.33 (+0.25%) ▲|PFE29.88-0.24 (-0.78%) ▼|PG157.97-1.35 (-0.85%) ▼|PLTR196.90+4.30 (+2.23%) ▲|PM196.25-3.66 (-1.83%) ▼|QCOM176.25+0.54 (+0.31%) ▲|RTX191.35-1.99 (-1.03%) ▼|SBUX98.62-0.75 (-0.75%) ▼|SCHW91.23+0.34 (+0.37%) ▲|SO90.40-0.32 (-0.35%) ▼|SPG205.54-1.46 (-0.70%) ▼|T22.01-1.41 (-6.02%) ▼|TMO690.98+3.61 (+0.53%) ▲|TMUS153.72-4.04 (-2.56%) ▼|TSLA386.41+12.70 (+3.40%) ▲|TXN282.60+4.82 (+1.73%) ▲|UBER68.42-0.52 (-0.75%) ▼|UNH417.07-2.19 (-0.52%) ▼|UNP290.03+2.42 (+0.84%) ▲|UPS99.03+0.51 (+0.51%) ▲|USB59.03-0.06 (-0.10%) ▼|V407.04+0.47 (+0.12%) ▲|VZ43.39-1.16 (-2.59%) ▼|WFC81.86-0.34 (-0.41%) ▼|WMT117.51-0.34 (-0.29%) ▼|XOM177.96+0.10 (+0.06%) ▲|AAPL341.15+1.65 (+0.49%) ▲|ABBV286.36-2.60 (-0.90%) ▼|ABT99.16-3.29 (-3.21%) ▼|ACN239.63+0.51 (+0.21%) ▲|ADBE256.33-0.40 (-0.16%) ▼|AMAT407.98+3.00 (+0.74%) ▲|AMD542.98+8.24 (+1.54%) ▲|AMGN436.48-2.46 (-0.56%) ▼|AMT179.77-3.79 (-2.06%) ▼|AMZN260.04-2.59 (-0.99%) ▼|AVGO333.80-0.57 (-0.17%) ▼|AXP321.75+3.41 (+1.07%) ▲|BA191.87+1.40 (+0.74%) ▲|BAC50.73+0.09 (+0.18%) ▲|BKNG157.99-5.93 (-3.62%) ▼|BLK1,132.51+3.83 (+0.34%) ▲|BMY61.25-0.44 (-0.71%) ▼|BNY145.28+1.03 (+0.71%) ▲|BRK-B541.72+1.90 (+0.35%) ▲|C122.60+0.09 (+0.07%) ▲|CAT734.01+8.77 (+1.21%) ▲|CL93.58-0.96 (-1.02%) ▼|CMCSA21.80-0.57 (-2.53%) ▼|COF209.72+8.16 (+4.05%) ▲|COP146.24+0.29 (+0.20%) ▲|COST990.15-4.46 (-0.45%) ▼|CRM241.54-0.90 (-0.37%) ▼|CSCO107.36+0.65 (+0.60%) ▲|CVS94.10-0.66 (-0.69%) ▼|CVX226.91+1.20 (+0.53%) ▲|DE628.79-3.41 (-0.54%) ▼|DHR228.90+4.66 (+2.08%) ▲|DIS110.58-1.09 (-0.98%) ▼|DUK121.17-0.16 (-0.13%) ▼|EMR161.89+1.43 (+0.89%) ▲|FDX298.94+0.18 (+0.06%) ▲|GD345.69+1.25 (+0.36%) ▲|GE304.97+5.10 (+1.70%) ▲|GEV921.39+31.06 (+3.49%) ▲|GILD152.75-3.76 (-2.40%) ▼|GM75.77-1.32 (-1.71%) ▼|GOOG327.00-9.40 (-2.79%) ▼|GOOGL331.07-9.21 (-2.71%) ▼|GS891.05+6.24 (+0.70%) ▲|HD313.58-1.53 (-0.48%) ▼|HON214.76+1.44 (+0.67%) ▲|IBM244.12+2.20 (+0.91%) ▲|INTC91.80+0.11 (+0.11%) ▲|INTU333.34-1.96 (-0.58%) ▼|ISRG418.37-19.63 (-4.48%) ▼|JNJ255.38-3.99 (-1.54%) ▼|JPM333.44-1.82 (-0.54%) ▼|KO92.86-0.64 (-0.68%) ▼|LIN500.09-1.80 (-0.36%) ▼|LLY1,266.98-16.68 (-1.30%) ▼|LMT548.71+0.00 (+0.00%) ▲|LOW195.92-1.36 (-0.69%) ▼|LRCX265.10+1.65 (+0.63%) ▲|MA621.11+0.69 (+0.11%) ▲|MCD244.10-2.42 (-0.98%) ▼|MDLZ63.16-0.83 (-1.30%) ▼|MDT93.77-0.87 (-0.91%) ▼|META704.66+10.41 (+1.50%) ▲|MMM170.67-0.70 (-0.41%) ▼|MO74.12-0.53 (-0.70%) ▼|MRK148.65+0.35 (+0.24%) ▲|MS181.69+1.29 (+0.72%) ▲|MSFT529.51-2.36 (-0.44%) ▼|MU904.87+8.80 (+0.98%) ▲|NEE78.56-0.30 (-0.38%) ▼|NFLX65.92-2.77 (-4.03%) ▼|NKE37.57-0.32 (-0.83%) ▼|NOW151.90+2.36 (+1.57%) ▲|NVDA218.12+1.65 (+0.76%) ▲|ORCL129.46-1.68 (-1.28%) ▼|PEP134.35+0.33 (+0.25%) ▲|PFE29.88-0.24 (-0.78%) ▼|PG157.97-1.35 (-0.85%) ▼|PLTR196.90+4.30 (+2.23%) ▲|PM196.25-3.66 (-1.83%) ▼|QCOM176.25+0.54 (+0.31%) ▲|RTX191.35-1.99 (-1.03%) ▼|SBUX98.62-0.75 (-0.75%) ▼|SCHW91.23+0.34 (+0.37%) ▲|SO90.40-0.32 (-0.35%) ▼|SPG205.54-1.46 (-0.70%) ▼|T22.01-1.41 (-6.02%) ▼|TMO690.98+3.61 (+0.53%) ▲|TMUS153.72-4.04 (-2.56%) ▼|TSLA386.41+12.70 (+3.40%) ▲|TXN282.60+4.82 (+1.73%) ▲|UBER68.42-0.52 (-0.75%) ▼|UNH417.07-2.19 (-0.52%) ▼|UNP290.03+2.42 (+0.84%) ▲|UPS99.03+0.51 (+0.51%) ▲|USB59.03-0.06 (-0.10%) ▼|V407.04+0.47 (+0.12%) ▲|VZ43.39-1.16 (-2.59%) ▼|WFC81.86-0.34 (-0.41%) ▼|WMT117.51-0.34 (-0.29%) ▼|XOM177.96+0.10 (+0.06%) ▲|
10.7 C
New York
Wednesday, October 21, 2026

Tag: surgery

Viatris Announces Five Data Presentations on Novel Fast-Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Conference

Presentations to include efficacy, safety and opioid use reduction data in two different surgery models as well as pharmacokinetics data  PITTSBURGH, Aug. 1, 2025 /PRNewswire/...

Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures

CARLSBAD, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient Prospective Payment Systems Final Rule (IPPS) for fiscal year (FY) 2026, the Centers for Medicare & Medicaid Services (CMS) granted New Technology Add-On Payment (NTAP) reimbursement to cervical fusion procedures using the company’s aprevo® personalized interbody implants.

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives

HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the appointment of Justin Van Fleet, CPA, as Chief Financial Officer, effective August 1, 2025.

NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO

NEW YORK, July 31, 2025 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor....

Osteosarcoma Market on the Rise in the 7MM During the Forecast Period (2025-2034) with Novel Therapeutics and Technological Innovations | DelveInsight

The dynamics of the osteosarcoma market are anticipated to change due to the extensive R&D activities, entry of novel potential therapies such as HALMB-0168...

Osteosarcoma Market on the Rise in the 7MM During the Forecast Period (2025-2034) with Novel Therapeutics and Technological Innovations | DelveInsight

The dynamics of the osteosarcoma market are anticipated to change due to the extensive R&D activities, entry of novel potential therapies such as HALMB-0168...

Artivion to Participate in Upcoming Investor Conferences

ATLANTA, July 30, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it...

Perimeter Announces Closing of Final Tranche of Prospectus Offering for $2.25 Million; Total Gross Proceeds of $5.35 Million Raised Under Prospectus Offering

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO and DALLAS, July 29, 2025 /CNW/ - Perimeter Medical...

RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES IN THE FIRST HALF OF 2025 REVENUE +11.7%, EBITDA(1) +9.6%, ADJUSTED NET INCOME(2) +8.9%

Milan, 29th July 2025 – The Board of Directors of Recordati S.p.A. approved the interim financial statements as of June 30, 2025, pursuant to Art. 154-ter of Italian Legislative Decree 58/1998 and subsequent amendments, prepared in accordance with said Decree and the CONSOB Issuers Regulation. The statements were prepared in accordance with International Accounting Standard (IAS) 34 requirements for interim reporting, based on the assessment, measurement and recognition criteria set by the IFRSs. The interim financial statements on June 30, 2025 – as well as the Independent Auditors’ report on such statements - will be available within the legal deadline at the company’s offices and on the company’s website (www.recordati.com) and can also be viewed on the authorized storage system 1Info(www.1Info.it).

Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery

Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery

Biosurgery Market worth US$21.59 Billion by 2030 with 6.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 28, 2025 /PRNewswire/ -- The global Biosurgery Market, valued at US$14.96 billion in 2024 stood at US$15.83 billion in 2025 and...

Biosurgery Market worth US$21.59 Billion by 2030 with 6.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 28, 2025 /PRNewswire/ -- The global Biosurgery Market, valued at US$14.96 billion in 2024 stood at US$15.83 billion in 2025 and...

Interventional Robot’s RCT Research Published in JNIS, a Leading Journal in Neurointervention!

SHANGHAI, July 28, 2025 /PRNewswire/ -- The multicenter, randomized controlled trial (RCT) results of the PANVIS-A® NeuroInterventional Robotic System—led by Professor Liu Jianmin (Changhai Hospital)...

ELIXIR MD, Inc. Expands into Mexico Through Strategic Partnership with Dr. Leonardo Moreno-Tevizo and Dr. Andrés Bello Margalef to Launch the Innovative ELIXIR MD™...

IRVINE, Calif. and MEXICO CITY, July 22, 2025 /PRNewswire/ -- ELIXIR MD, Inc., a pioneer in advanced aesthetic non-invasive medical technology and treatment protocols, is...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSurgery